Lawrence F. Eichenfield

Pediatrics

3020 Childrens Way
San Diego, CA 92123

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 377 publications

Nailed it? A diagnostic puzzle in an infant.

Nailed it? A diagnostic puzzle in an infant.

Journal: JAAD case reports

Published: August 09, 2026

Topical Therapy for Atopic Dermatitis: What is New and the New Paradigm.

Topical Therapy for Atopic Dermatitis: What is New and the New Paradigm.

Journal: Immunology and allergy clinics of North America

Published: July 09, 2026

Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus.

Assessment and Clinical Management of Patients With Atopic Dermatitis Undergoing Patch Testing: Recommendations From an International Electronic Delphi Consensus.

Journal: Dermatitis : contact, atopic, occupational, drug

Published: June 30, 2026

The role of aryl hydrocarbon receptor agonists in the management of inflammatory skin diseases: An expert consensus panel.

The role of aryl hydrocarbon receptor agonists in the management of inflammatory skin diseases: An expert consensus panel.

Journal: Dermatology online journal

Published: June 25, 2026

Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, ICONIC-TOTAL, and ICONIC-ADVANCE 1 and 2 Phase 3 Trials.

Safety of Icotrokinra Through 1 Year for the Treatment of Moderate-to-Severe Plaque Psoriasis and Psoriasis Affecting High-Impact Sites: Pooled Results Across the ICONIC-LEAD, ICONIC-TOTAL, and ICONIC-ADVANCE 1 and 2 Phase 3 Trials.

Journal: Dermatology and therapy

Published: June 24, 2026

Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

Journal: The Journal of dermatological treatment

Published: June 11, 2026

Safety of Dupilumab and Risk of Cutaneous T-Cell Lymphoma in Pediatric Patients With Atopic Dermatitis: A Data-Driven Guide to Counseling Patients and Families.

Safety of Dupilumab and Risk of Cutaneous T-Cell Lymphoma in Pediatric Patients With Atopic Dermatitis: A Data-Driven Guide to Counseling Patients and Families.

Journal: Pediatric dermatology

Published: March 23, 2026

Improvements in clinical and patient-reported outcomes and durability of response with the targeted oral peptide icotrokinra in adolescents with moderate-to-severe plaque psoriasis: One-year results from the ICONIC-LEAD randomized controlled trial.

Improvements in clinical and patient-reported outcomes and durability of response with the targeted oral peptide icotrokinra in adolescents with moderate-to-severe plaque psoriasis: One-year results from the ICONIC-LEAD randomized controlled trial.

Journal: Journal of the American Academy of Dermatology

Published: February 20, 2026

Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex.

Efficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex.

Journal: Journal of drugs in dermatology : JDD

Published: February 05, 2026

Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial.

Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial.

Journal: Dermatology and therapy

Published: January 30, 2026

Long-Term Dupilumab Treatment Is Not Associated with an Increased Overall Risk of Infections in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label 5-Year Extension Study.

Long-Term Dupilumab Treatment Is Not Associated with an Increased Overall Risk of Infections in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label 5-Year Extension Study.

Journal: Advances in therapy

Published: January 21, 2026

Guidelines of care for the primary prevention of atopic dermatitis and awareness of comorbid conditions in pediatric atopic dermatitis.

Guidelines of care for the primary prevention of atopic dermatitis and awareness of comorbid conditions in pediatric atopic dermatitis.

Journal: Journal of the American Academy of Dermatology

Published: January 15, 2026

Showing 1-12 of 377

Last Updated: 09/26/2026